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Abstract
Purpose
Retinal detachment (RD) is one of the most frequently diagnosed ophthalmologic conditions
requiring prompt surgical intervention. Combination of proper surgical technique and new
diagnostic markers, both clinical and molecular, can help improve the diagnosis and progno-
sis of RD treatment.
Methods
12 patients with rhegmatogenous RD (rRD) were included into the study after obtaining
patient consent and Regional Ethical Approval (average age: 58.1 ± 17.4 years). OCT was
performed before and after 23G vitrectomy for RD. Pure subretinal fluid (SRF) was collected
during surgery and analyzed by protein array profiling on a panel of 105 inflammatory cyto-
kines (Human XL Cytokine Array), while the effect of SRF upon human macrophages-driven
phagocytosis of apoptotic retinal pigment epithelial (RPE) cells ex vivo was quantified by
flow cytometry. Immunohistochemistry (IHC) of retinectomized tissue due to PVR caused
by RD was performed to determine presence of markers for microglial cells (CD34), macro-
phages and activated microglia (CD68), regulator of the immune response to infection
(NFkB), progenitor and stem cell marker (Sox2), pluripotency marker (Oct4) and intermedi-
ate filament markers (GFAP and Nestin).
Results
OCT of fresh RD patients contained pre-operatively hyper reflective points (HRPs) at the
detached neuroretina border and proximal to the RPE layer—their size and number
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decreased following successful reattachment surgery. IHC of the retinectomized tissue from
detached retina due to severe PVR showed presence of cell conglomerates at the detached
neuroretina border which were positive for CD68, NFkB, Sox2 and GFAP, less positive for
CD47 and Nestin and negative for Oct4 and CD34. The SRF contained at least 37 cytokines
with higher, and 4 cytokine with lower concentration compared to that in vitreous from non-
RD pathology; when used as conditional medium to human macrophages ex vivo, the SRF
doubled their capacity for engulfing dying RPEs.
Conclusions
Fresh RD can be hallmarked by presence of HRPs at the detached neuroretina border on
OCT; the HRPs decrease in size and number after successful reattachment surgery, and
likely resemble the macrophage conglomerates seen by IHC. The neuroretina in RD con-
tains progenitor/stem-like cells and signs of inflammatory reaction, while the SRF contains
inflammatory cytokines and other factors which increase the ability of professional phago-
cytes to engulf dying RPE, or for that matter, other dying cells in the retina.
Introduction
Retinal detachment (RD) is one of the most serious and damaging disorders of the retina and
vision, requiring prompt surgical action. The incidence of RD ranges from 1:10000–15000 per
year, most patients being 50 years of age or older [1, 2]. Delayed or improper surgical treat-
ment of patients in the acute phase of the disease can cause severe to permanent visual
impairment. Beside the clinical signs seen by ophthalmoscopy, ultrasound and alternatively,
optical coherence tomography (OCT) can be used to confirm the diagnosis.
OCT is a light-based imaging modality that can be used in biological systems to study tis-
sues in vivo with near-histological, ultrahigh resolution [3–5]. Hyperreflective points (HRPs)
have been detected by OCT and studied in relation to diseases like retinitis pigmentosa [6],
macular holes [7], diabetic macular edema [4], age-related macular degeneration [8], adenovi-
rus keratoconjunctivitis [9] or uveitis [10]. It has also been shown that such HRPs are aggre-
gates of activated microglia cells [11]. Their presence, number and location serve as a
prognostic factor in many of these diseases.
We hereby present a study in which OCT scans of eyes with fresh rhegmatogenous RD
(rRD) were performed before and after RD surgery to observe for presence or change of the
number of HRPs in the neuroretina and near the border with the retinal pigment epithelium
(RPE), from which the neuroretina got detached. Correlation with cellular aggregates found
by immunohistochemistry on retinectomized tissue due to proliferative vitreoretinopathy
(PVR) caused by RD was performed to determine presence of markers for microglia (CD34),
macrophages and activated microglia (CD68), regulator of the immune response to infection
(NFkB), progenitor and stem cell marker (Sox2), pluripotency marker (Oct4) and intermediate
filament markers (GFAP and Nestin).
Furthermore, the subretinal fluid (SRF) found between the neuroretina and the underlying
RPE layer, which is secreted by the RPE cells, was studied since its composition is still not fully
known. It is assumed that the SRF contains cytokines which play an important role in the RD,
which is actually a sterile form of inflammation [12].
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The present study aimed to find a reliable clinical marker which can be a putative marker
for RD as well as prognostic factor for surgical success or outcome, next to finding molecular
markers such as presence of inflammatory cytokines in the SRF, and the effect of SRF upon
dead cell clearance in the retina.
Materials and methods
Tissue collection and cultivation of cells
All tissue collection complied with the Guidelines of the Helsinki Declaration (1964) and was
approved by the National Medical Ethics Committee of the Republic of Slovenia (Ref. No.
112/01/13). Twelve patients with rRD (7 females, 5 males), all having detached macula, were
included in the study after written informed consent was obtained. Average age of the patients
was 58.1 ± 17.4 years.
OCT examination and HRP quantification
12 rRD patients underwent an OCT scan of the retina during the study (Nidek RS-3000
Advance). Two images were made from each eye before and after repair surgery for RD (23G
pars plana vitrectomy) upon clear optical media appearance. The images were compared in
the same level plane with special regard to the presence of HRP at the two time points.
Quantification of the HRPs was initially performed manually, and then by a less subjective
interpretation. The original tiff files were segmented by adjustment of brightness at numerical
68 contrast at numerical 123 within the levels tool in Image J. The dynamic range threshold
was adjusted to help isolate the cells of interest and subtract the background, then a “Contrast
Limited Adaptive Histogram Equalization” (CLAHE) filter was used to normalize the contrast
values. The cell shape and size were present as between 20–40 pixels in diameter and measured
within the Region of Interest (ROI) selected equally for OCT images analyzed.
Immunohistochemical (IHC) analysis
Paraffin embedded sections fixed in formalin (4%) from retinectomized tissue due to severe
PVR caused by RD were analyzed by classical Hematoxylin & Eosin (H&E)- and immune-
staining for presence of microglia cell marker (CD34) and viability/’don’t-eat-me’ signal
marker (CD47). Presence of macrosialin—a heavily glycosylated transmembrane protein of
87-115kD, which is specifically expressed by tissue macrophages, Langerhans cells and at low
levels by dendritic cells—the murine homologue of the human macrophage glycoprotein
(CD68) was checked. Furthermore, (NFkB)-regulator of the immune response to infection,
(Sox2)-progenitor and stem cell marker, (Oct4)-pluripotency marker and (GFAP and Nestin)-
intermediate filament markers were checked. Incubation was carried out at room temperature
for 60 minutes. The chromogen substrate was DAB with incubation lasting for 1–3 minutes at
room temperature.
SRF sample collection and measurement of inflammatory cytokines
Undiluted/pure SRF samples were obtained during vitrectomy for primary rRD using a 41G
needle. Control samples/vitreous were obtained from uneventful vitrectomies (VC) for non-
RD pathology (e.g. epiretinal fibrosis surgery). All samples were collected in sterile polypropyl-
ene tubes and stored at −20˚C until analysis. Sample volumes ranged between 100–700 μL.
A semi-quantitative array (Proteome Profiler, Human XL Cytokine Array Kit, Bio-Techne,
USA) was purchased to determine the cytokine profile of the SRF and non-RD vitreous body.
Samples were thawed on ice and prepared according to the manufacturer’s guidelines. Briefly,
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4 donors of SRF and 4 donors of control vitreous body were pooled (to reduce the inter-donor
variability) and centrifuged at 2500 RPM for 5 minutes to sediment any debris. The mem-
branes (arrays) with the antibodies were blocked, then the samples were applied on two sepa-
rate arrays and incubated overnight at 4˚C with agitation. The following day, after washing the
membranes, a cocktail of detection antibodies was applied on the arrays, followed by an incu-
bation in a streptavidin-HRP solution. For visualization, a chemiluminescent reagent was
pipetted on the membranes and images were taken by an ImageQuant LAS 4000 mini device.
The membranes were exposed to light for 10 minutes and images were recorded.
Dot blot analysis was carried out using ImageJ. Briefly, the background was subtracted
from the image and the ‘raw integrated density’ of each individual dot (printed in duplicates)
was determined (sum of the values of the pixels in the selection). Results were visualized in
Microsoft Excel.
In vitro analysis of the effect of SRF upon the clearance of dying RPE cells
by human macrophages
Quantification of the phagocytic capacity of macrophages engulfing anoikic dying ARPE cells
in presence or absence of SRF (50:50% conditional medium) was performed. Human mono-
cytes were isolated from ‘buffy coats’ of healthy blood donors on Ficoll–Paque Plus (Amer-
sham Bio-sciences, Uppsala, Sweden) gradient and magnetic separation using CD14 human
microbeads (Miltenyi Biotec, Auburn, CA, USA). Human macrophages were obtained
through a 5-day differentiation using 5 ng/ ml macrophage colony-stimulating factor (Pepro-
tech EC, London, United Kingdom). Dying ARPE-19 cells were fed to macrophages 24 hrs
after the induction of anoikis. Pre-treatment of macrophages with the SRF conditional
medium was performed 48 hrs prior to the assay. The macrophages were stained with 7.5 μM
CMTMR (Invitrogen) for16 hrs, washed twice in phosphate-buffered saline (PBS) before start-
ing the assay. The cells being engulfed were stained with 12.5 μM CFDA for 16 hrs before the
phagocytosis and washed twice in PBS before being added to the phagocytes. The ratio of
phagocytes and cells to be engulfed was set at 1:5. The phagocytosis assay started when the
cells to be engulfed were added to the appropriate phagocytes and kept together for 4 hrs. The
assay was ended by trypsinizing the phagocytic cell mixture to remove bound but not engulfed
dying cells, centrifuging, washing twice in PBS and fixing in 1% PBS-buffered paraformalde-
hyde (pH 7.4). The phagocytosis rate was determined by FACS analysis as percent phagocytic
cells (CMTMR positive) that have engulfed dying cells (positive for both CMTMR and CFDA)
as described by our group previously [13].
Results
Presence of HRP on OCT before and after surgery for rRD
OCT scans were performed on all patients studied with RD: one before surgery, while the
detachment was still fresh, and one after surgery, upon clear media appearance. HRPs were
detected before surgery in the neuroretina, more abundantly in the outer retinal layers of the
neuroretina, near the detached border from the RPE layer. The HRPs decreased in size and
number upon successful reattachment following vitrectomy (Fig 1A and 1B).
Immunohistochemical analysis was performed on detached neuroretina which was retinec-
tomized due to presence of PVR, to see the structural changes and detect the expression of dif-
ferent markers in the tissue (Figs 2 and 3). The IHC low expression of CD47 positive cells (Fig
2B). Cellular aggregates positive for CD68 (marker for all types of macrophages, but likely M2
type of macrophages or alternatively activated ones) could be detected (Fig 2C). Furthermore,
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the detached neuroretina was positive for NFkB (Fig 2D), which plays a role in the expression
of pro-inflammatory genes includiwng cytokines, chemokines, and adhesion molecules [14],
as well as Sox 2—progenitor and stem cell marker (Fig 3A), and the intermediate filament
marker GFAP (Fig 3B), while being somewhat less positive for Nestin (Fig 3C) and negative
for Oct4 (Fig 3D).
Semi-quantitative analysis of inflammatory cytokines in the SRF from RD
38 cytokines were identified in the SRF samples: Adiponectin, Angiogenin, Apolipoprotein A-
1, BAFF, BDNF, CD14, CD31, Chitinase 3-like 1, Complement Component C5/C5a, Comple-
ment Factor D, C-Reactive Protein, Cystatin C, Dkk-1, DPPIV, Emmprin, Endoglin, FGF-19,
Flt-3 Ligand, GDF-15, HGF, ICAM-1, IGFBP-2, IGFBP-3, IL-18 Bpa, IL-8, Lipocalin-2, MCP-
1, MIF, Osteopontin, RBP-4, SDF-1α, Serpin E1, SHBG, TIM-3, uPAR, VCAM-1, VEGF and
Vitamin D BP. The VC contained 11 individual cytokines: Angiogenin, Apolipoprotein A-1,
CD14, Chitinase 3-like 1, Complement Factor D, Cystatin C, MIF, Osteopontin, Pentraxin-3,
RBP-4 and Vitamin D BP (Fig 4A).
Increased level of secretion of Angiogenin (1.5-fold), Apolipoprotein A-1 (2.9-fold), CD14
(4.2-fold), Complement Factor D (2.0-fold) and RBP-4 (1.4-fold) were detected in the SRF
compared to the controls, while decreased levels were detected for Chitinase 3-like 1 (1.2-fold),
Fig 1. Presence of HR points in the retina before and after surgery for rRD. (A) HR points are shown in the square box. OCT image from the retina
when detached (image above) and after reattachment surgery (image below) showing absence of subretinal fluid and diminishing presence of HR points
in the neuroretina. (B) Medians and Interquartile range of number of HR points counted on OCT images during the pre- (RD) and post-
(reattachment) state (outliers being shown as separate dots).
https://doi.org/10.1371/journal.pone.0217548.g001
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Fig 2. Expression of hematopoietic, macrophage and inflammatory pathway markers is shown on a
retinectomized tissue from RD with PVR. Immunohistochemical analysis is shown against CD47 (B), CD68 (C) and
NFkB (D) at magnification 10X (left column) and 40x (right column).
https://doi.org/10.1371/journal.pone.0217548.g002
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MIF (3.0-fold), Osteopontin (1.6-fold) and Vitamin D BP (0.9-fold), accordingly. (Fig 4B)
Cystatin C was detected in both SRF and control samples in equal quantities, while Pentraxin-
3 was detected in the controls only and not the SRF. The remaining 27 cytokines were identi-
fied exclusively in the SRF and were not detectable in the vitreous controls.
Fig 3. Expression of stem/progenitor cell-, neuro-glial markers. Immunohistochemical analysis is shown against
Sox2 (A), GFAP (B), Nestin (C) and Oct4 (D) at magnification 10X (left column) and 40x (right column).
https://doi.org/10.1371/journal.pone.0217548.g003
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Fig 4. Semi-quantitative proteome profiler cytokine array. Individual cytokines detected in SRF (blue bars) versus VC (orange
bars) are plotted against pixel density values (y-axis) (A). The difference in the cytokines detected in both SRF and VC are
represented (B) as the fold change difference in SRF compared to VC.
https://doi.org/10.1371/journal.pone.0217548.g004
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SRF enhances phagocytosis of dying RPE cells by macrophages
The SRF/conditional medium enhanced significantly or two-fold the phagocytosis percent car-
ried out by macrophages engulfing dying ARPE-19 cells (p<0.05). This phagocytosis enhanc-
ing effect of the SRF was higher than that caused by the known enhancer of the phagocytosis
process (triamcinolone, TC) and showed no additive or cumulative effect upon TC+SRF treat-
ment (Fig 5).
Discussion
A RD is relatively common and severe disorder of the eye which involves cellular mechanisms
such as inflammation and cell death in its pathogenesis. The inflammation is sterile without
any presence of infection. The most common form of RD is rRD, which occurs as a result of a
full-thickness retinal break. Vitreoretinal traction takes role in rRD by allowing accumulation
of liquefied vitreous under the retina leading to its separation from the RPE. Accordingly,
there are few precursors to such a type of RD, including liquefied vitreous, tractional forces
and break through which fluid gains access to the subretinal space [15, 16].
The pathomechanism of RD can be divided into actions occurring during the acute phase
of the detachment, and actions during the chronic phase, which is hallmarked by proliferative
vitreoretinopathy (PVR). The earliest structural effects of RD can be seen on the outer seg-
ments (OS) of the photoreceptors and RPE cells. Between these two structures, there are no
actual cellular junctions in the mature eye, but they are adherent through the numerous micro-
villi present on the apical surface of the RPE. Upon RD, these connections become damaged
and a space between the two cellular layers is formed. The subretinal space is usually free of cel-
lular content, but during RD, cells like neutrophils, monocytes and macrophages can migrate
into the damaged area together with migrating RPE cells. The damaged OS of the photorecep-
tors also flow into the subretinal space, where they become phagocytosed by RPEs or other
phagocytes present in the vicinity. Within 24 hours from RD, microglia-like cells have been
shown to display signs of proliferation [17].
The precise nature of HRPs remains elusive [18]. HRPs have been previously studied in
other eye disorders, and correlations to their microglial origin has been shown in some of
them, but to the best of our knowledge, not in RD. It is known that microglial cells are impor-
tant participants in the inflammatory response and, therefore, their presence can be presumed
whenever inflammation is seen [19]. It has also been suggested that HRPs may be leucocytes
or RPE cells, indicating retinal inflammation in itself. An alternative theory about the origin of
HRPs is that they may represent small intraretinal proteins or lipid deposits, acting as a precur-
sor of hard exudates or as an indication of lipoprotein extravasation, after the breakdown of
the inner blood-retina barrier, usually present in patients with diabetic retinopathy (DR) and
retinal vein occlusion. Furthermore, there are suggestions that HRPs are the result of neurode-
generative processes that occur in diabetes even before the development of clinical signs of DR
[18]. Ideally, after surgical intervention, the neuroretina should return back to its original posi-
tion, which is adherent to the RPE layer, accompanied by attenuation of the inflammatory
cells. Decreased or remaining HRPs on OCT can therefore refer to remaining inflammation,
thus provide a prognostic measure of the success of reattachment surgery. Nevertheless,
recently, presence of residual SRF between the neuroretina and the RPE layer has been shown
to be beneficial for the success of reattachment, probably due to presence of different factors,
likely other than inflammatory factors, in the SRF, which may have beneficial effect in the cell
survival and cell-to-cell reattachment.
Macrophages and microglial cells have several functions like scavenging, cytotoxic func-
tions, antigen presentation, synaptic stripping, promotion of repair, extracellular signaling or
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Fig 5. Phagocytosis study of macrophages (MF) engulfing dying ARPE-19 cells upon treatment with conditional
medium containing 50% subretinal fluid, as well as triamcinolone (TC). The dot plots are representative images of
the flow cytometry analysis of the engulfment process under the shown conditions (R1 represents the population of
macrophages which have engulfed dying ARPE-19 cells, while R2 represents macrophages which have not engulfed
dying cells). (�) represent statistical significance (p<0.05) of n = 8 samples.
https://doi.org/10.1371/journal.pone.0217548.g005
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phagocytosis. The microglial cells are normally active in the CNS and dormant in the retina,
but during RD they, together with the monocyte-macrophage surveillance system can become
activated and start to divide and/or migrate to the border of the neuroretina and RPE layer
[20–22]. Several studies have shown that macrophages are recruited to the subretinal space
through the Bruch’s membrane and the RPE monolayer during RD [23]. CD68, a cell surface
marker for macrophages has been previously reported to be expressed by cultured RPE cells
[24]. Macrophages have specific receptors such as lipopolysaccharide receptor CD14, phospha-
tidylserine receptors, the integrin receptor αvβ3, and the scavenger receptors SRA1 and CD36
which take role in apoptotic cell removal by recognizing phosphatidylserine, oxidized lipids,
and other unidentified phagocytic signals exposed by apoptotic cells. We could identify cell
aggregates in the detached neuroretina retinectomized from RD with PVR to be positive for
the macrophage marker CD68, and negative for microglial and M1 macrophage cell marker
CD34, respectively. IHC could indeed reveal increased presence and aggregation of inflamma-
tory/ phagocytic cells at the neuroretina / RPE border during RD, resembling very much the
HRPs seen on OCT in a similar location. Furthermore, CD47, a member of the Ig cell adhesion
molecule family, is expressed by virtually all cells in the body. Pharmacological activation of
CD47 has been shown to accelerate resolution of subretinal and peritoneal inflammation, with
implications for treatment of chronic inflammatory diseases and possibly other conditions
[25–27].
NFkB an important regulator of the innate immune response, an inhibitor of some cell deg-
radation/autophagic processes, and involved in aging is another marker that was expressed in
the detached neuroretina. Its expression appeared to be limited, however, to the vascular endo-
thelial cells, which may correlate with the finding of another study showing NFkB to play an
important role in maintaining constitutive VEGF secretion in the RPE/choroid complex [28].
SOX2 is required at all major stages of retinal development for the proper formation of the
mammalian eye and has an important role in maintaining neural progenitor/stem cell proper-
ties and in converting fibroblasts into pluripotent stem cells [29–31]. In the detached neurore-
tina, there was a high expression of this marker, indicating abundance of cells with potential to
proliferate and differentiate into another cell type; meanwhile, no expression of the pluripo-
tency marker Oct4 could be detected in the analyzed samples. It has been shown that silencing
of the expression of Oct4 in mice Mu¨ller glial (MG) cells after retinal damage, and prevention
of the silencing of this pluripotency-associated gene after injury, may possibly improve the
transition from MG to retinal progenitor cells, leading to MG-mediated retina regeneration
[32].
Upregulation of GFAP has been an indicator of stress in CNS astrocytes. The retina
responds similarly to stress by upregulating this intermediate filament first in the MG cells. An
increase in the GFAP in MG cells has indeed been shown after RD [33, 34] which could also be
seen in our case in the detached neuroretina sample.
Nestin is another intermediate filament marker for neural progenitor cells that may play a
part in the maintenance of the normal retina. Nestin positive cells in the adult human retina
show morphological and geographical similarity to neurons, including retinal ganglion cells,
other neurons, and MG cells [35, 36]. An upregulation of Nestin expression in the retinal
microglia, macrophages, and MG cells has been shown before in adult mice undergoing phar-
maceutical induction of retinal degeneration, implicating that Nestin may be used as an early-
stage marker of acute retinal injury [37]. Following injury, however, microglial cells become
activated and express Nestin, which appears to be the cells in some of the cells in our detached
neuroretina.
The resident ocular cells react to damage stimuli by altering the chemokine levels in which
an important role take the RPE cells following an appropriate stimulus. Contact with the
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vitreous or monocytes, stimulation by pro-inflammatory cytokines, and mechanical injury
have all been shown to be a trigger for the production and secretion of chemokines by RPEs
[12]. During RD, SRF fills out the gap between the detached neuroretina and the RPE layer,
becoming a ‘flooded’ area for inflammatory cytokines and chemokines. These cytokines have
several functions like regulation of different pathways including apoptosis and proliferative
changes in the retina, leading to PVR. The definitive source of such factors is still not clear, but
most likely a major source for their production are the monocytes and retinal glial cells like
microglia or Mu¨ller cells that could have invaded the subretinal space [38]. Although the
blood-retina barrier gets damaged during RD, the level of the plasma cytokines does not seem
to reach high enough concentration to significantly contribute to the cytokine milieu found in
the subretinal space. The levels of 38 cytokines and other growth factors (determined by us
and other groups) appear to increase in the SRF, and contribute to the triggering and enhance-
ment of the inflammatory and immune responses seen during RD [39–43] compared to the
level of such cytokines in the vitreous of normal eyes. IL-6 plays an important role in inflam-
mation and immune responses, chemokine induction and recruitment of immune cells like
leukocytes as well as photoreceptor protecting function [39, 44, 45], which in the semi-quanti-
tative protein array analysis of SRF could not be detected, but appeared enhanced in the more
sensitive detection analysis of SRF by ELISA (S1 Fig). Similarly, IL-8 has a chemoattractant
effect on neutrophils and RPE cells, and is mostly produced by RPE cells [46].
The results of the IHC have been corroborated by profiling the secretion of the most
important inflammatory cytokines. Due to the RD, the usually cell-free subretinal spaced gets
infiltrated by neutrophils and monocytes/ macrophages, joined by cellular debris and photore-
ceptor OS [17]. As a result of the breakup of tissue integrity and the pro-inflammatory cyto-
kines secreted by the infiltrating monocytes/ macrophages, activation of the resident immune
cells and RPEs occurs [23].
Macrophages have been shown to infiltrate the subretinal space through the RPE and
through the Bruch‘s membrane [12], which can be evidenced also by SRF-contained cytokines
which are otherwise expressed in macrophages (CD14, CD31, ICAM-1, Osteopontin, MIF),
and factors secreted by macrophages as a result of stimuli (Chitinase 3-like 1, IL-8, MCP-1). It
is possible, that these factors enhance macrophages functions, such as phagocytosis (e.g. Com-
plement Component C5/C5a, C- reactive protein, IL-8) [20], and assist the transmigration of
more immune cells (e.g. CD31, Complement Component C5/C5a, ICAM-1, Osteopontin,
VCAM-1). The exact source of the pro-inflammatory cytokines is unknown, however, our
results suggest that macrophages play a major role in the process and these cells have been
identified on our IHC sections. RD and the self- aggregating, pro- inflammatory process ulti-
mately leads to proliferative vitreoretinopathy (PVR) formation, and as such, the presence of
pro-inflammatory, fibrotic factors were found in the SRF (Chitinase 3-like 1, DPPIV, FGF-19,
Serpin E1 [PAI-1], uPAR) along with other potent inducers of angiogenesis (Angiogenin,
CD31, Endoglin, HGF, IL-8, SDF-1a, VEGF). To elaborate, whether inhibition of macrophage
infiltration or function could dampen over-activation and prevent PVR needs to be further
investigated with more exact, quantitative methods and a larger sample size.
Upregulation of the inflammatory mediators’ expression in the vitreous or SRF from
patients with vitreoretinal disorders might have a negative effect upon the inflammation
response and induce the proliferation and differentiation of RPE cells [47]. In our case, robust
presence of stem/progenitor-like cells which were positive for Sox2 could be observed in the
neuroretina from RD. Whether these cells are the source for the inflammatory or phagocytic
cells or the consequence of the released inflammatory factors in the SRF by macrophages or
other phagocytic cell types remains to be further studied. Besides cytokines and growth factors,
the SRF contains some yet unknown factors which have enhancing effect upon phagocytic
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activity of macrophages and other cells of the immune system. This is clearly shown by the
effect of our SRF conditional medium, which could enhance significantly the capacity of mac-
rophages to engulf dying RPE cells ex vivo. In RD, the main function of the macrophages
would be to phagocytose dying cells and help RPE cells in the clearance and survival/death
processes. The role of specific and non- specific macrophages has been described in detail
before [13, 20]. In addition, some of the factors detected and upregulated in SRF are angio-
genic promoters and play roles in wound healing and tissue remodeling.
A limitation of the present and similar studies is that, to the best of our knowledge, no ani-
mal model exists for induction of RD rhegmatogenously, but rather mechanically, without
presence of comparable ‘sterile’ inflammation as seen in humans in vivo. Furthermore, the use
of semi-quantitative methods to study the proteome profile certainly needs validation by more
sensitive methods like ELISA.
Overall, the present study shows for the first time the presence of HRP in the detached neu-
roretina layer which is put in correlation with the success of reattachment post-operatively.
This is a relatively easy, simple, repeatable, non-invasive method for determining changes dur-
ing RD and the success of surgery in the follow-up period. Presence of inflammatory and
growth factors in the SRF as well as cellular reaction in the retina may serve as potential targets
for drug therapy aimed at decreasing inflammation and cell death seen during RD.
Supporting information
S1 Fig. Concentration of IL-6 and IL-8 in the subretinal fluid from rRD determined by
ELISA. Data shown are mean + S.D. from ten independent patient samples of SRF.
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